Literature DB >> 28095189

The unmet clinical need of novel antifungal drugs.

Damian J Krysan1.   

Abstract

Keywords:  anti-infectives; antifungal

Mesh：

Substances：

Year:  2017        PMID： 28095189      PMCID： PMC5354155          DOI： 10.1080/21505594.2016.1276692

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  19 in total

Review 1.  Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.

Authors:  Laura L Kovanda; Rochelle Maher; William W Hope
Journal:  Expert Rev Clin Pharmacol       Date:  2016-05-21       Impact factor: 5.045

2.  Emergence of Candida auris: An International Call to Arms.

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

Review 3.  Trehalose pathway as an antifungal target.

Authors:  John R Perfect; Jennifer L Tenor; Yi Miao; Richard G Brennan
Journal:  Virulence       Date:  2016-06-01       Impact factor: 5.882

Review 4.  Antifungal drug development: challenges, unmet clinical needs, and new approaches.

Authors:  Terry Roemer; Damian J Krysan
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

Review 5.  Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.

Authors:  Praveen R Juvvadi; Soo Chan Lee; Joseph Heitman; William J Steinbach
Journal:  Virulence       Date:  2016-06-20       Impact factor: 5.882

Review 6.  Exploiting mitochondria as targets for the development of new antifungals.

Authors:  Dongmei Li; Richard Calderone
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

7.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

Review 8.  Echinocandin Resistance in Candida Species: a Review of Recent Developments.

Authors:  Nathan P Wiederhold
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

Review 9.  Toward improved anti-cryptococcal drugs: Novel molecules and repurposed drugs.

Authors:  Damian J Krysan
Journal:  Fungal Genet Biol       Date:  2014-12-13       Impact factor: 3.495

10.  Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.

Authors:  Joshua Rhein; Bozena M Morawski; Kathy Huppler Hullsiek; Henry W Nabeta; Reuben Kiggundu; Lillian Tugume; Abdu Musubire; Andrew Akampurira; Kyle D Smith; Ali Alhadab; Darlisha A Williams; Mahsa Abassi; Nathan C Bahr; Sruti S Velamakanni; James Fisher; Kirsten Nielsen; David B Meya; David R Boulware
Journal:  Lancet Infect Dis       Date:  2016-03-10       Impact factor: 25.071
View more
  7 in total

1.  Discovery of diazahexa/hepta cyclic cage-like compounds with broad-spectrum antifungal activity against Candida and Cryptococcus species.

Authors:  Anthony Weinstock; Natarajan Arumugam; Abdulrahman I Almansour; Raju Suresh Kumar; Shankar Thangamani
Journal:  RSC Adv       Date:  2019-09-20       Impact factor: 4.036

2.  Lactoferrin-Derived Peptide Lactofungin Is Potently Synergistic with Amphotericin B.

Authors:  Kenya E Fernandes; Richard J Payne; Dee A Carter
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 3.  Drug resistance and tolerance in fungi.

Authors:  Judith Berman; Damian J Krysan
Journal:  Nat Rev Microbiol       Date:  2020-02-11       Impact factor: 60.633

4.  Ultra-fast proteomics with Scanning SWATH.

Authors:  Christoph B Messner; Vadim Demichev; Nic Bloomfield; Jason S L Yu; Matthew White; Marco Kreidl; Anna-Sophia Egger; Anja Freiwald; Gordana Ivosev; Fras Wasim; Aleksej Zelezniak; Linda Jürgens; Norbert Suttorp; Leif Erik Sander; Florian Kurth; Kathryn S Lilley; Michael Mülleder; Stephen Tate; Markus Ralser
Journal:  Nat Biotechnol       Date:  2021-03-25       Impact factor: 54.908

5.  Lineages Derived from Cryptococcus neoformans Type Strain H99 Support a Link between the Capacity to Be Pleomorphic and Virulence.

Authors:  Kenya E Fernandes; James A Fraser; Dee A Carter
Journal:  mBio       Date:  2022-03-08       Impact factor: 7.786

6.  Novel Hybrid Formulations Based on Thiourea Derivatives and Core@Shell Fe₃O₄@C18 Nanostructures for the Development of Antifungal Strategies.

Authors:  Carmen Limban; Alexandru Vasile Missir; Miron Teodor Caproiu; Alexandru Mihai Grumezescu; Mariana Carmen Chifiriuc; Coralia Bleotu; Luminita Marutescu; Marius Toma Papacocea; Diana Camelia Nuta
Journal:  Nanomaterials (Basel)       Date:  2018-01-17       Impact factor: 5.076

7.  Functional information from clinically-derived drug resistant forms of the Candida glabrata Pdr1 transcription factor.

Authors:  Lucia Simonicova; W Scott Moye-Rowley
Journal:  PLoS Genet       Date:  2020-08-25       Impact factor: 5.917
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.